FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-6026 | 26436-6026-1 | Nadide | 200 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5558 | 26436-5558-5 | Nadide | 50 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5556 | 26436-5556-1 | Naltrexone | 4.5 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-0724 | 26436-0724-9 | Naltrexone | 2 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5614 | 26436-5614-1 | Naltrexone Hydrochloride Dihydrate | 2.5 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5615 | 26436-5615-1 | Naltrexone Hydrochloride Dihydrate | 3.5 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5610 | 26436-5610-1 | Naltrexone Hydrochloride Dihydrate | 1 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5611 | 26436-5611-1 | Naltrexone Hydrochloride Dihydrate | 3 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 200 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5066 | 26436-5066-3 | Niacinamide | 100 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 8 mg/250 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-049 | 68985-049-91 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-004 | 68985-004-94 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 6 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-153 | 68985-153-85 | Amiodarone Hydrochloride | 1.8 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-91 | Heparin Sodium | 10 U/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-95 | Heparin Sodium | 10 U/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 20 mg/1 mL; 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 8 mg/8 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-349 | 83298-349-04 | Tirzepatide | 2.5 mg/.5 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-354 | 83298-354-04 | Tirzepatide | 15 mg/.5 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-305 | 83298-305-07 | Epinephrine | 5 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-339 | 83298-339-10 | Epinephrine; Bupivacaine Hydrochloride | .05 mg/10 mL; 25 mg/10 mL | 2024-1 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-308 | 83298-308-03 | Atropine Sulfate | .4 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 50 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1370 | 61141-1370-5 | Ropivacaine Hydrochloride | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2024-1 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1027 | 70657-1027-5 | Semaglutide | 2.5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1014 | 70657-1014-3 | Glutathione | 200 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1026 | 70657-1026-3 | Inositol; Methionine | 50 mg/1 mL; 25 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1223 | 70657-1223-3 | Methylcobalamin | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1019 | 70657-1019-3 | Niacinamide; Pyridoxine; Thiamine Hydrochloride; Riboflavin 5'-Phosphate Sodium | 100 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL; 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Molecular PharmaGroup | 080602630 | 72790-004 | 72790-004-05 | Dehydrated Alcohol | 2.1 mL/3 mL | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6706 | 71300-6706-4 | Baclofen | 20 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-2 | Baclofen | 50 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-4 | Baclofen | 50 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6617 | 71300-6617-1 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6631 | 71300-6631-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6564 | 71300-6564-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2024-1 | valid | 2026-11-08 |